Skip to Main Content

Paper Details

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Nat Commun
21
2021
Author NameAffiliation
Bego??a CamposHospital Lucus Agusti
Jose A Lopez-MartinHospital 12 de Octubre
  • 1 - 2

Datasets

Release 1.2